secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-09-18T23:59:59+00:00
Accession:  0001493152-25-014073
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric raises $2.2M in warrant exercise inducement; issues new Series C/D warrants
--------------------------------------------------------------------------------

- Holders exercised 1,212,499 Series A and 1,212,499 Series B warrants at reduced price of $0.915/share.
- Gross proceeds ~$2.2M; H.C. Wainwright acted as placement agent (7% fee).
- Company issued new unregistered Series C (2,424,998 shares, 5-yr term) and Series D (2,424,998 shares, 18-mo term) warrants at $0.915.
- New warrants exercisable only after stockholder approval; proceeds for working capital and product development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225014073/0001493152-25-014073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225014073/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer